When did GILEAD SCIENCES INC (GILD) report earnings last quarter?
GILEAD SCIENCES INC (GILD) last reported earnings on 2/10/2026.
NASDAQ:GILD • US3755581036
Past quarterly earnings results for GILEAD SCIENCES INC (GILD), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.86 | 1.85 | 0.73% | -2.11% | 7.925B | 7.848B | 0.98% | 4.70% |
| Q3 2025 | 2.47 | 2.17 | 13.68% | 22.28% | 7.769B | 7.595B | 2.29% | 2.97% |
| Q2 2025 | 2.01 | 2.00 | 0.60% | - | 7.082B | 7.104B | -0.31% | 1.84% |
| Q1 2025 | 1.81 | 1.82 | -0.59% | 237.12% | 6.667B | 6.942B | -3.96% | -0.28% |
| Q4 2024 | 1.90 | 1.74 | 9.39% | 10.47% | 7.569B | 7.287B | 3.87% | 6.38% |
| Q3 2024 | 2.02 | 1.59 | 27.44% | -11.79% | 7.545B | 7.144B | 5.61% | 7.01% |
| Q2 2024 | 2.01 | 1.63 | 23.18% | 21.08% | 6.954B | 6.853B | 1.47% | 5.38% |
| Q1 2024 | -1.32 | -1.52 | 13.32% | -196.35% | 6.686B | 6.467B | 3.39% | 5.26% |
| Q4 2023 | 1.72 | 1.79 | -4.16% | 2.99% | 7.115B | 7.243B | -1.77% | -3.71% |
| Q3 2023 | 2.29 | 1.96 | 17.10% | 20.53% | 7.051B | 6.938B | 1.63% | 0.13% |
| Q2 2023 | 1.66 | 1.68 | -0.92% | 5.06% | 6.599B | 6.573B | 0.40% | 5.42% |
| Q1 2023 | 1.37 | 1.57 | -12.56% | -35.38% | 6.352B | 6.46B | -1.67% | -3.61% |
| Q4 2022 | 1.67 | 1.52 | 9.52% | 142.03% | 7.389B | 6.774B | 9.08% | 2.00% |
| Q3 2022 | 1.90 | 1.45 | 30.66% | -28.30% | 7.042B | 6.246B | 12.74% | -5.11% |
| Q2 2022 | 1.58 | 1.55 | 2.16% | -15.51% | 6.26B | 5.969B | 4.88% | 0.69% |
| Q1 2022 | 2.12 | 1.84 | 15.00% | 1.92% | 6.59B | 6.401B | 2.95% | 2.60% |
| Q4 2021 | 0.69 | 1.62 | -57.52% | -68.49% | 7.244B | 6.793B | 6.64% | -2.39% |
| Q3 2021 | 2.65 | 1.78 | 48.53% | 25.59% | 7.421B | 6.403B | 15.90% | 12.83% |
| Q2 2021 | 1.87 | 1.77 | 5.70% | 68.47% | 6.217B | 6.192B | 0.40% | 20.88% |
| Q1 2021 | 2.08 | 2.13 | -2.39% | 23.81% | 6.423B | 6.88B | -6.64% | 15.77% |
| Q4 2020 | 2.19 | 2.19 | -0.14% | - | 7.421B | 7.475B | -0.72% | - |
| Q3 2020 | 2.11 | 1.94 | 8.89% | - | 6.577B | 6.44B | 2.13% | - |
| Q2 2020 | 1.11 | 1.48 | -24.81% | - | 5.143B | 5.411B | -4.95% | - |
| Q1 2020 | 1.68 | 1.61 | 4.58% | - | 5.548B | 5.561B | -0.23% | - |
Notes
GILEAD SCIENCES INC (GILD) last reported earnings on 2/10/2026.
GILEAD SCIENCES INC (GILD) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, GILEAD SCIENCES INC (GILD) has beaten EPS estimates in 3 out of 4 releases.